Peripheral Neurogenic PainNCT07662421
Slump Lateral Bending Test Diagnostic Accuracy in Lumbar Radicular Pain
An observational study of Peripheral Neurogenic Pain, run by Fisiopoint Parma Physiotherapy at 1 site in Italy.
Trial summary
This observational diagnostic accuracy study will evaluate the ability of the Slump Lateral Bending Test to identify patients with suspected peripheral neurogenic pain or neural mechanosensitivity. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Peripheral Neurogenic Pain
- How many people
- 280 participants
- Where
- 1 siteItaly
- Study dates
- 23 Jun 2026to 15 Jun 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients with suspected peripheral neurogenic pain or neural mechanosensitivity who are referred for physiotherapy assessment will be considered for inclusion. Participants may present with symptoms such as pain, paresthesia, dysesthesia, or movement-related symptoms potentially associated with peripheral nerve involvement. Eligible patients will undergo a standardized clinical assessment including neurological and neurodynamic examination procedures, including the Slump Lateral Bending Test.
Who may be able to join
- Adults aged 18 years or older.
- Patients with suspected peripheral neurogenic pain or neural mechanosensitivity.
- Presence of symptoms potentially related to peripheral nerve involvement, such as:
- pain;
- paresthesia;
- dysesthesia;
Show all 9Show fewer
- symptoms modified by neurodynamic positioning.
- Ability to understand the study procedures and provide written informed consent.
- Ability to undergo the clinical, neurological, and neurodynamic assessment procedures required by the study.
Who cannot join
- Age under 18 years.
- Inability to provide informed consent.
- Presence of severe neurological disease or central nervous system disorder that may interfere with clinical assessment.
- Previous major surgery or trauma affecting the assessed body region, if it may compromise interpretation of the clinical tests.
- Acute inflammatory, infectious, or systemic disease that may explain the symptoms or contraindicate clinical testing.
- Severe pain or clinical condition preventing safe execution of the Slump Lateral Bending Test or other neurodynamic tests.
- Pregnancy, if neurodynamic testing is considered inappropriate or not clinically indicated.
- Inability to understand instructions or complete the assessment procedures.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Fisiopoint Parma
Parma, PR, 43125
Paolo Bertacchini, 3387607400, paoberta@libero.it
About this study
Official title: Diagnostic Accuracy of the Slump Lateral Bending Test for MRI-Confirmed Lumbar Radicular Involvement: A Multicenter Prospective Observational Study
This observational diagnostic accuracy study will evaluate the ability of the Slump Lateral Bending Test to identify patients with suspected peripheral neurogenic pain or neural mechanosensitivity. Adult participants will be assessed using clinical examination procedures, including the Slump Lateral Bending Test and other neurological and neurodynamic findings. Thes study aims to determine whether this test may help clinicians recognize patients in whom peripheral nerve involvement contributes to symptoms. The results may support clinical reasoning in physiotherapy and improve the assessment o patients with suspected neurogenic pain.
- Conditions
- Peripheral Neurogenic Pain
- Keywords
- Slump Lateral Bending Test, Neurodynamic test, Peripheral neurogenic pain,
What is being measured
The primary outcome is the main question the study is designed to answer.
Sensitivity and Specificity of the SLBT for MRI-Confirmed Lumbar Nerve Root Contact or Compression
Sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios, and overall diagnostic accuracy of the Slump Lateral Bending Test will be calculated using lumbar MRI findings classified as nerve root contact or compression as the reference standard.
Measured: At baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jun 2026
- Study start23 Jun 2026
- Primary completion15 Jun 2029 (estimated)
- Study completion15 Jun 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Peripheral Neurogenic PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 280 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fisiopoint Parma Physiotherapy
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07662421
- Sponsor's protocol ID
- SLBT-2026
- Status last verified
- Sep 2026
- First submitted
- 13 Jun 2026
- Last updated
- 3 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Diagnostic Accuracy of the Slump Lateral Bending Test for MRI-Confirmed Lumbar Radicular Involvement: A Multicenter Prospective Observational Study
- ClinicalTrials.gov ID
- NCT07662421
- Acronym / sponsor ID
- SLBT-2026
- Conditions
- Peripheral Neurogenic Pain
- Keywords
- Slump Lateral Bending Test, Neurodynamic test, Peripheral neurogenic pain,
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 280 participants (estimated)
- Lead sponsor
- Fisiopoint Parma PhysiotherapyUniversity, hospital or other
- Study start
- 23 Jun 2026 (actual)
- Primary completion
- 15 Jun 2029 (estimated)
- Study completion
- 15 Jun 2029 (estimated)
- First posted
- 23 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This observational diagnostic accuracy study will evaluate the ability of the Slump Lateral Bending Test to identify patients with suspected peripheral neurogenic pain or neural mechanosensitivity. Adult participants will be assessed using clinical examination procedures, including the Slump Lateral Bending Test and other neurological and neurodynamic findings. Thes study aims to determine whether this test may help clinicians recognize patients in whom peripheral nerve involvement contributes to symptoms. The results may support clinical reasoning in physiotherapy and improve the assessment o patients with suspected neurogenic pain.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients with suspected peripheral neurogenic pain or neural mechanosensitivity who are referred for physiotherapy assessment will be considered for inclusion. Participants may present with symptoms such as pain, paresthesia, dysesthesia, or movement-related symptoms potentially associated with peripheral nerve involvement. Eligible patients will undergo a standardized clinical assessment including neurological and neurodynamic examination procedures, including the Slump Lateral Bending Test.
Key inclusion criteria (9 listed)
- Adults aged 18 years or older.
- Patients with suspected peripheral neurogenic pain or neural mechanosensitivity.
- Presence of symptoms potentially related to peripheral nerve involvement, such as:
- pain;
- paresthesia;
Key exclusion criteria (8 listed)
- Age under 18 years.
- Inability to provide informed consent.
- Presence of severe neurological disease or central nervous system disorder that may interfere with clinical assessment.
- Previous major surgery or trauma affecting the assessed body region, if it may compromise interpretation of the clinical tests.
- Acute inflammatory, infectious, or systemic disease that may explain the symptoms or contraindicate clinical testing.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Sensitivity and Specificity of the SLBT for MRI-Confirmed Lumbar Nerve Root Contact or Compression
Time frame: At baseline
Sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios, and overall diagnostic accuracy of the Slump Lateral Bending Test will be calculated using lumbar MRI findings classified as nerve root contact or compression as the reference standard.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2026.
Related trials for Peripheral Neurogenic Pain
Not yet recruiting
Segmental Decompression Versus Wide Decompression With Fixation for Degenerative Lumbar Canal Stenosis
Degenerative Lumbar Spinal Stenosis
Active, not recruitingObservational study
Effectiveness and Safety of Korean Medicine for Low Back Pain or Sciatica Due to Lumbar Stenosis/Spondylolisthesis
Lumbar Spinal Stenosis, Lumbar Spondylolisthesis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Peripheral Neurogenic Pain, run by Fisiopoint Parma Physiotherapy at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sensitivity and Specificity of the SLBT for MRI-Confirmed Lumbar Nerve Root Contact or Compression (time frame: At baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.